Annual accounts receivable:
$9.63B-$38.00M(-0.39%)Summary
- As of today (August 22, 2025), TMO annual accounts receivable is $9.63 billion, with the most recent change of -$38.00 million (-0.39%) on December 31, 2024.
- During the last 3 years, TMO annual accounts receivable has risen by +$681.00 million (+7.61%).
- TMO annual accounts receivable is now -0.39% below its all-time high of $9.66 billion, reached on December 31, 2023.
Performance
TMO Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$10.04B+$214.00M(+2.18%)Summary
- As of today (August 22, 2025), TMO quarterly accounts receivable is $10.04 billion, with the most recent change of +$214.00 million (+2.18%) on June 28, 2025.
- Over the past year, TMO quarterly accounts receivable has increased by +$605.00 million (+6.42%).
- TMO quarterly accounts receivable is now at all-time high.
Performance
TMO Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TMO Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.4% | +6.4% |
| 3 y3 years | +7.6% | +12.8% |
| 5 y5 years | +94.4% | +94.3% |
TMO Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.4% | +7.6% | at high | +12.8% |
| 5 y | 5-year | -0.4% | +94.4% | at high | +94.3% |
| alltime | all time | -0.4% | >+9999.0% | at high | +2423.9% |
TMO Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $10.04B(+2.2%) |
| Mar 2025 | - | $9.82B(+2.0%) |
| Dec 2024 | $9.63B(-0.4%) | $9.63B(-1.7%) |
| Sep 2024 | - | $9.80B(+3.9%) |
| Jun 2024 | - | $9.43B(+0.8%) |
| Mar 2024 | - | $9.35B(-3.2%) |
| Dec 2023 | $9.66B(+2.5%) | $9.66B(-1.7%) |
| Sep 2023 | - | $9.84B(+3.7%) |
| Jun 2023 | - | $9.49B(+2.0%) |
| Mar 2023 | - | $9.30B(-1.4%) |
| Dec 2022 | $9.43B(+5.4%) | $9.43B(+5.7%) |
| Sep 2022 | - | $8.92B(+0.3%) |
| Jun 2022 | - | $8.89B(-0.7%) |
| Mar 2022 | - | $8.95B(+0.1%) |
| Dec 2021 | $8.95B(+38.2%) | $8.95B(+40.5%) |
| Sep 2021 | - | $6.37B(+1.4%) |
| Jun 2021 | - | $6.28B(-0.9%) |
| Mar 2021 | - | $6.34B(-2.1%) |
| Dec 2020 | $6.47B(+30.7%) | $6.47B(+10.0%) |
| Sep 2020 | - | $5.88B(+13.9%) |
| Jun 2020 | - | $5.16B(-0.0%) |
| Mar 2020 | - | $5.17B(+4.3%) |
| Dec 2019 | $4.95B(+7.8%) | $4.95B(-0.8%) |
| Sep 2019 | - | $4.99B(+4.6%) |
| Jun 2019 | - | $4.78B(+1.6%) |
| Mar 2019 | - | $4.70B(+2.3%) |
| Dec 2018 | $4.59B(+18.5%) | $4.59B(+19.3%) |
| Sep 2018 | - | $3.85B(-1.5%) |
| Jun 2018 | - | $3.91B(-2.0%) |
| Mar 2018 | - | $3.99B(+2.9%) |
| Dec 2017 | $3.88B(+27.2%) | $3.88B(+6.1%) |
| Sep 2017 | - | $3.66B(+12.2%) |
| Jun 2017 | - | $3.26B(+5.2%) |
| Mar 2017 | - | $3.10B(+1.6%) |
| Dec 2016 | $3.05B(+19.8%) | $3.05B(+5.3%) |
| Sep 2016 | - | $2.90B(+6.9%) |
| Jun 2016 | - | $2.71B(+1.5%) |
| Mar 2016 | - | $2.67B(+4.8%) |
| Dec 2015 | $2.54B(+2.9%) | $2.54B(+0.0%) |
| Sep 2015 | - | $2.54B(-3.3%) |
| Jun 2015 | - | $2.63B(+3.7%) |
| Mar 2015 | - | $2.54B(+2.6%) |
| Dec 2014 | $2.47B(+27.4%) | $2.47B(-1.3%) |
| Sep 2014 | - | $2.51B(-5.8%) |
| Jun 2014 | - | $2.66B(-1.3%) |
| Mar 2014 | - | $2.70B(+38.8%) |
| Dec 2013 | $1.94B | $1.94B(-0.1%) |
| Sep 2013 | - | $1.95B(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $1.90B(-0.2%) |
| Mar 2013 | - | $1.90B(+5.5%) |
| Dec 2012 | $1.80B(+2.3%) | $1.80B(-1.3%) |
| Sep 2012 | - | $1.83B(+1.4%) |
| Jun 2012 | - | $1.80B(-4.8%) |
| Mar 2012 | - | $1.89B(+4.4%) |
| Dec 2011 | $1.76B(+16.3%) | $1.81B(+0.2%) |
| Sep 2011 | - | $1.81B(+7.6%) |
| Jun 2011 | - | $1.68B(+7.5%) |
| Mar 2011 | - | $1.57B(+3.2%) |
| Dec 2010 | $1.52B(+7.6%) | $1.52B(-2.9%) |
| Sep 2010 | - | $1.56B(+6.1%) |
| Jun 2010 | - | $1.47B(-1.4%) |
| Mar 2010 | - | $1.49B(+6.0%) |
| Dec 2009 | $1.41B(-4.6%) | $1.41B(-4.9%) |
| Sep 2009 | - | $1.48B(+0.8%) |
| Jun 2009 | - | $1.47B(+3.3%) |
| Mar 2009 | - | $1.42B(-3.7%) |
| Dec 2008 | $1.48B(+1.9%) | $1.48B(-4.2%) |
| Sep 2008 | - | $1.54B(-3.5%) |
| Jun 2008 | - | $1.60B(+0.8%) |
| Mar 2008 | - | $1.59B(+9.4%) |
| Dec 2007 | $1.45B(+4.1%) | $1.45B(-0.6%) |
| Sep 2007 | - | $1.46B(+2.5%) |
| Jun 2007 | - | $1.42B(+0.2%) |
| Mar 2007 | - | $1.42B(+1.9%) |
| Dec 2006 | $1.39B(+146.3%) | $1.39B(+158.0%) |
| Sep 2006 | - | $539.84M(-0.9%) |
| Jun 2006 | - | $544.52M(+0.3%) |
| Mar 2006 | - | $542.93M(-4.0%) |
| Dec 2005 | $565.56M(+20.4%) | $565.56M(+8.5%) |
| Sep 2005 | - | $521.38M(+1.7%) |
| Jun 2005 | - | $512.65M(+11.8%) |
| Mar 2005 | - | $458.56M(+6.7%) |
| Dec 2004 | $469.55M(+1.9%) | - |
| Dec 2003 | $460.93M(+7.3%) | - |
| Dec 2002 | $429.74M(+1685.3%) | $429.74M(-0.1%) |
| Sep 2002 | - | $430.32M(+4.7%) |
| Jun 2002 | - | $411.15M(+3.4%) |
| Mar 2002 | - | $397.61M(-3.2%) |
| Dec 2001 | $24.07M(-94.7%) | $410.96M(-0.3%) |
| Sep 2001 | - | $412.35M(+1.7%) |
| Jun 2001 | - | $405.53M(-5.4%) |
| Mar 2001 | - | $428.46M(-4.8%) |
| Dec 2000 | $450.00M(+2322.6%) | $450.00M |
| Dec 1999 | $18.57M(-98.1%) | - |
| Dec 1998 | $962.65M(+1287.6%) | - |
| Dec 1997 | $69.38M | - |
FAQ
- What is Thermo Fisher Scientific Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Thermo Fisher Scientific Inc.?
- What is Thermo Fisher Scientific Inc. annual accounts receivable year-on-year change?
- What is Thermo Fisher Scientific Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Thermo Fisher Scientific Inc.?
- What is Thermo Fisher Scientific Inc. quarterly accounts receivable year-on-year change?
What is Thermo Fisher Scientific Inc. annual accounts receivable?
The current annual accounts receivable of TMO is $9.63B
What is the all time high annual accounts receivable for Thermo Fisher Scientific Inc.?
Thermo Fisher Scientific Inc. all-time high annual accounts receivable is $9.66B
What is Thermo Fisher Scientific Inc. annual accounts receivable year-on-year change?
Over the past year, TMO annual accounts receivable has changed by -$38.00M (-0.39%)
What is Thermo Fisher Scientific Inc. quarterly accounts receivable?
The current quarterly accounts receivable of TMO is $10.04B
What is the all time high quarterly accounts receivable for Thermo Fisher Scientific Inc.?
Thermo Fisher Scientific Inc. all-time high quarterly accounts receivable is $10.04B
What is Thermo Fisher Scientific Inc. quarterly accounts receivable year-on-year change?
Over the past year, TMO quarterly accounts receivable has changed by +$605.00M (+6.42%)